Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Portuguese and British scientists develop mathematical model that explains variability in tuberculosis vaccine efficacy

04.03.2004


Scientists at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, together with colleagues at the Universities of Lisbon and Warwick, in the United Kingdom, have developed a mathematical model that explains why the tuberculosis (TB) vaccine is ineffective in many of the developing countries. The model quantifies the predicted decrease in the number of TB cases in light of both the socioeconomic development of a population and the characteristics of new vaccines. Their research has been published in the Proceedings of the Royal Society (22nd March edition).



The efficacy of the bacille Calmette-Guérin (BCG) vaccine (the only vaccine in current use against tuberculosis) is variable, and there is no consensus about its usefulness. Estimates of protection range from 80% in the United Kingdom to around 0% in India, for example. For 30 years now scientists have tried to unravel the role of socioeconomic, genetic and environmental factors in generating this broad range of protection. This new model highlights socioeconomic factors (namely population density, access to primary healthcare, sanitation and diet, amongst others), which influence the dissemination of the infeccious agent.

The scientists estimate that the efficacy of the BCG vaccine decreases as the number of cases of TB increases, leading to a positive feedback loop, whose effect becomes most evident when the transmission potential reaches the reinfection threshold (a newly-defined concept). Other factors are expected to be involved, but no other model to date has been able to reproduce the magnitude of observed trends.


According to Gabriela Gomes, head of the Theoretical Epidemiology group at the IGC, the model shows that the vaccine is successful in blocking transmission in a population whose transmission potential is below the reinfection threshold (in these cases, most of the TB cases are due to primary infections). In those populations where the transmission potential exceeds the reinfection threshold, on the other hand, the protective effect of the vaccine is literally obliterated by the high levels of reinfection. The model predicts that, in these populations, only a vaccine with a stronger protective effect than a previous infection will successfully reduce transmission of tuberculosis.

In developed countries, the TB transmission potential is well below the reinfection threshold, due, largely, to major improvements in socioeconomic conditions, begun the mid-1800s. In less developed countries, on the other hand, the incidence of TB is up to 100 times higher. The poor socioeconomic conditions increase the potential for transmission, to levels clearly above the reinfection threshold. In these countries, changes in socioeconomic conditions are slow and difficult, therefore the scientists propose that the development of more potent vaccines is a more realistically hopeful measure for keeping TB under control. Their model also indicates the desired characteristics for such vaccines.

In Portugal the situation appears to one of delicate equilibrium, wherein any change may be sharply amplified. The number of reported cases of TB in Portugal points to transmission levels close to the reinfection threshold. The model predicts, therefore, that efforts to control tuberculosis will be greatly rewarded, but inattentiveness may result in a sharp rise in the number of cases.

The conclusions and predictions of this model are applicable to other diseases for which primary infection does not induce solid immunity. These diseases are kept prevalent by the high number of reinfections (malaria is an example of such a disease).

“This research underscores how important it is to combine mathematical modelling with experimental research in order to better understand infectious diseases, and developing effective therapeutical strategies”, says Antonio Coutinho, Director of the IGC.

Ana Coutinho | alfa
Further information:
http://www.igc.gulbenkian.pt

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>